Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Issa Sabi

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Plos One|September 19, 2025
Evaluation of QIAreach QuantiFERON-TB lateral-flow nanoparticle fluorescence assay for TB infection diagnosis among TB household contacts in three high-burden settingsThobani Ntshiqa, Akinlolu Fasanmi, Jeniffer Nagudi, et al.
Trials|June 10, 2022
Rifapentine and isoniazid for prevention of tuberculosis in people with diabetes (PROTID): protocol for a randomised controlled trialNyanda Elias Ntinginya, Lindsey Te Brake, Issa Sabi, et al.
BMJ Open|November 9, 2022
Indicators of optimal diabetes care and burden of diabetes complications in Africa: a systematic review and meta-analysisDavis Kibirige, Nyasatu Chamba, Irene Andia-Biraro, et al.
The Pediatric Infectious Disease Journal|February 28, 2023
Rapid and Accurate Diagnosis of Pediatric Tuberculosis Disease: A Diagnostic Accuracy Study for Pediatric TuberculosisLaura Olbrich, Marriott Nliwasa, Issa Sabi, et al.
Scientific Reports|November 14, 2023
Burden and associated phenotypic characteristics of tuberculosis infection in adult Africans with diabetes: a systematic reviewDavis Kibirige, Irene Andia-Biraro, Andrew Peter Kyazze, et al.
The Lancet. Infectious Diseases|November 2, 2023
Diagnostic accuracy of a three-gene Mycobacterium tuberculosis host response cartridge using fingerstick blood for childhood tuberculosis: a multicentre prospective study in low-income and middle-income countriesLaura Olbrich, Valsan P Verghese, Zoe Franckling-Smith, et al.
The Lancet. Infectious Diseases|September 23, 2024
Sequential and parallel testing for microbiological confirmation of tuberculosis disease in children in five low-income and middle-income countries: a secondary analysis of the RaPaed-TB studyLaura Olbrich, Zoe Franckling-Smith, Leyla Larsson, et al.
BMC Infectious Diseases|August 15, 2024
Expanding Xpert MTB/RIF Ultra® and LF-LAM testing for diagnosis of tuberculosis among HIV-positive adults admitted to hospitals in Tanzania and Mozambique: a randomized controlled trial (the EXULTANT trial)Chacha Mangu, Marta Cossa, Robert Ndege, et al.
The Lancet. Infectious Diseases|May 9, 2026
Expanding Xpert MTB/RIF Ultra and lateral flow urine lipoarabinomannan testing for diagnosis of tuberculosis among adults living with HIV admitted to hospitals in Tanzania and Mozambique (EXULTANT): a randomised controlled trialMarta Cossa, Robert Ndege, Bindiya Meggi, et al.
Trials|February 26, 2026
panTB-HM: a multi-arm clinical trial of a pan-TB regimen targeting both host and microbeD Mudzengi, S Mashatole, Q Xiang, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Plos One|September 19, 2025
Evaluation of QIAreach QuantiFERON-TB lateral-flow nanoparticle fluorescence assay for TB infection diagnosis among TB household contacts in three high-burden settingsThobani Ntshiqa, Akinlolu Fasanmi, Jeniffer Nagudi, et al.
Trials|June 10, 2022
Rifapentine and isoniazid for prevention of tuberculosis in people with diabetes (PROTID): protocol for a randomised controlled trialNyanda Elias Ntinginya, Lindsey Te Brake, Issa Sabi, et al.
BMJ Open|November 9, 2022
Indicators of optimal diabetes care and burden of diabetes complications in Africa: a systematic review and meta-analysisDavis Kibirige, Nyasatu Chamba, Irene Andia-Biraro, et al.
The Pediatric Infectious Disease Journal|February 28, 2023
Rapid and Accurate Diagnosis of Pediatric Tuberculosis Disease: A Diagnostic Accuracy Study for Pediatric TuberculosisLaura Olbrich, Marriott Nliwasa, Issa Sabi, et al.
Scientific Reports|November 14, 2023
Burden and associated phenotypic characteristics of tuberculosis infection in adult Africans with diabetes: a systematic reviewDavis Kibirige, Irene Andia-Biraro, Andrew Peter Kyazze, et al.
The Lancet. Infectious Diseases|November 2, 2023
Diagnostic accuracy of a three-gene Mycobacterium tuberculosis host response cartridge using fingerstick blood for childhood tuberculosis: a multicentre prospective study in low-income and middle-income countriesLaura Olbrich, Valsan P Verghese, Zoe Franckling-Smith, et al.
The Lancet. Infectious Diseases|September 23, 2024
Sequential and parallel testing for microbiological confirmation of tuberculosis disease in children in five low-income and middle-income countries: a secondary analysis of the RaPaed-TB studyLaura Olbrich, Zoe Franckling-Smith, Leyla Larsson, et al.
BMC Infectious Diseases|August 15, 2024
Expanding Xpert MTB/RIF Ultra® and LF-LAM testing for diagnosis of tuberculosis among HIV-positive adults admitted to hospitals in Tanzania and Mozambique: a randomized controlled trial (the EXULTANT trial)Chacha Mangu, Marta Cossa, Robert Ndege, et al.
The Lancet. Infectious Diseases|May 9, 2026
Expanding Xpert MTB/RIF Ultra and lateral flow urine lipoarabinomannan testing for diagnosis of tuberculosis among adults living with HIV admitted to hospitals in Tanzania and Mozambique (EXULTANT): a randomised controlled trialMarta Cossa, Robert Ndege, Bindiya Meggi, et al.
Trials|February 26, 2026
panTB-HM: a multi-arm clinical trial of a pan-TB regimen targeting both host and microbeD Mudzengi, S Mashatole, Q Xiang, et al.
Pageof 5